| Biological properties of extracellular vesicles and their physiological functions M Yáñez-Mó, PRM Siljander, Z Andreu, A Bedina Zavec, FE Borràs, ... Journal of extracellular vesicles 4 (1), 27066, 2015 | 5383 | 2015 |
| Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells F Takeshita, CA Leifer, I Gursel, KJ Ishii, S Takeshita, M Gursel, ... The Journal of Immunology 167 (7), 3555-3558, 2001 | 790 | 2001 |
| Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs D Verthelyi, KJ Ishii, M Gursel, F Takeshita, DM Klinman The Journal of Immunology 166 (4), 2372-2377, 2001 | 714 | 2001 |
| Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation I Gursel, M Gursel, H Yamada, KJ Ishii, F Takeshita, DM Klinman The Journal of Immunology 171 (3), 1393-1400, 2003 | 322 | 2003 |
| Sterically stabilized cationic liposomes improve the uptake and immunostimulatory activity of CpG oligonucleotides I Gursel, M Gursel, KJ Ishii, DM Klinman The Journal of Immunology 167 (6), 3324-3328, 2001 | 272 | 2001 |
| Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9 F Takeshita, I Gursel, KJ Ishii, K Suzuki, M Gursel, DM Klinman Seminars in immunology 16 (1), 17-22, 2004 | 250 | 2004 |
| Is global BCG vaccination‐induced trained immunity relevant to the progression of SARS‐CoV‐2 pandemic? M Gursel, I Gursel Allergy 75 (7), 1815, 2020 | 206 | 2020 |
| Potential role of phosphatidylinositol 3 kinase, rather than DNA-dependent protein kinase, in CpG DNA–induced immune activation KJ Ishii, F Takeshita, I Gursel, M Gursel, J Conover, A Nussenzweig, ... The Journal of experimental medicine 196 (2), 269-274, 2002 | 175 | 2002 |
| CpG oligodeoxynucleotides protect normal and SIV-infected macaques from Leishmania infection D Verthelyi, M Gursel, RT Kenney, JD Lifson, S Liu, J Mican, DM Klinman The Journal of Immunology 170 (9), 4717-4723, 2003 | 162 | 2003 |
| Intestinal microbiota in patients with spinal cord injury B Gungor, E Adiguzel, I Gursel, B Yilmaz, M Gursel PloS one 11 (1), e0145878, 2016 | 158 | 2016 |
| Effect of suppressive DNA on CpG-induced immune activation H Yamada, I Gursel, F Takeshita, J Conover, KJ Ishii, M Gursel, ... The Journal of Immunology 169 (10), 5590-5594, 2002 | 146 | 2002 |
| Liposomes as immunological adjuvants and vaccine carriers G Gregoriadis, I Gursel, M Gursel, B McCormack Journal of Controlled Release 41 (1-2), 49-56, 1996 | 136 | 1996 |
| Suppressive oligodeoxynucleotides protect mice from lethal endotoxic shock H Shirota, I Gursel, M Gursel, DM Klinman The Journal of Immunology 174 (8), 4579-4583, 2005 | 130 | 2005 |
| Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics JP Figueroa, ME Bottazzi, P Hotez, C Batista, O Ergonul, S Gilbert, ... The Lancet 397 (10274), 562-564, 2021 | 124 | 2021 |
| CpG oligodeoxynucleotides induce human monocytes to mature into functional dendritic cells M Gursel, D Verthelyi, DM Klinman European journal of immunology 32 (9), 2617-2622, 2002 | 123 | 2002 |
| Suppressive oligodeoxynucleotides inhibit Th1 differentiation by blocking IFN-γ-and IL-12-mediated signaling H Shirota, M Gursel, DM Klinman The Journal of Immunology 173 (8), 5002-5007, 2004 | 116 | 2004 |
| CXCL16 influences the nature and specificity of CpG-induced immune activation M Gursel, I Gursel, HS Mostowski, DM Klinman The Journal of Immunology 177 (3), 1575-1580, 2006 | 105 | 2006 |
| Oligodeoxynucleotide and its use to induce an immune response D Klinman, D Verthelyi, K Ishii, JJ Mond, M Gursel US Patent 6,977,245, 2005 | 105 | 2005 |
| Operation Warp Speed: implications for global vaccine security JH Kim, P Hotez, C Batista, O Ergonul, JP Figueroa, S Gilbert, M Gursel, ... The Lancet Global Health 9 (7), e1017-e1021, 2021 | 104 | 2021 |
| CpG RNA: identification of novel single-stranded RNA that stimulates human CD14+ CD11c+ monocytes T Sugiyama, M Gursel, F Takeshita, C Coban, J Conover, T Kaisho, ... The Journal of Immunology 174 (4), 2273-2279, 2005 | 101 | 2005 |
